Advertisement

Archives of Virology

, Volume 70, Issue 1, pp 21–32 | Cite as

Thermal stability of foot-and-mouth disease virus

  • T. R. Doel
  • P. J. Baccarini
Original Papers

Summary

The thermal stabilities of 146S component of seven strains of foot-and-mouth disease virus were found to differ considerably. Inactivation of infectivity with acetylethyleneimine (AEI) reduced the thermal stabilities of all but one of the viruses. Treatment of AEI inactivated and control virus preparations with glutaraldehyde stabilized 146S particles to a considerable extent, whereas treatment with dimethyl suberimidate was less effective.

In similar experiments with 75S, natural empty particles, the thermal stabilities were lower than those of the corresponding 146S particles. Treatment of 75S particles with AEI appeared to have no direct effect on the protein-protein interactions involved in 75S capsid integrity. As with 146S particles, glutaraldehyde stabilized 75S particles.

Keywords

Infectious Disease Thermal Stability Direct Effect Dimethyl Glutaraldehyde 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bachrach, H. L., Trautman, R., Breese, S. S.: Chemical and physical properties of virtually pure foot-and-mouth disease virus. Amer. J. vet. Res.25, 333–342 (1964).Google Scholar
  2. 2.
    Barteling, S. J., Meloen, R. M.: A simple method for the quantification of 140S particles of foot-and-mouth disease virus. Arch. ges. Virusforsch.45, 362–364 (1974).Google Scholar
  3. 3.
    Brown, F., Cartwright, B.: Dissociation of foot-and-mouth disease virus into its nucleic acid and protein components. Nature192, 1163 (1961).Google Scholar
  4. 4.
    Brown, F., Newman, J. F. E.:In vitro measurement of the potency of inactivated foot-and-mouth disease vaccines. J. Hyg.61, 345–351 (1963).Google Scholar
  5. 5.
    Helmerhorst, E., Stokes, G. B.: Microcentrifuge desalting — a rapid quantitative method for desalting small amounts of protein. Anal. Biochem.104, 130–135 (1980).Google Scholar
  6. 6.
    Mowat, G. N., Masters, R. C., Prince, M. J.: Enhancement of immunising potency of a foot-and-mouth disease vaccine for cattle by treatment of the antigen with formaldehyde. Arch. ges. Virusforsch.41, 365–370 (1973).Google Scholar
  7. 7.
    Peters, K., Richards, F. M.: Chemical cross-linking reagents and problems in studies of membrane structure. Ann. Rev. Biochem.46, 523–551 (1977).Google Scholar
  8. 8.
    Randrup, A.: On the stability of bovine foot-and-mouth disease virus dependent on pH. Investigations on the complement-fixing and the immunising antigen as well as on the infective agent. Acta path. Microbiol. Scand.35, 388 (1954).Google Scholar
  9. 9.
    Rowlands, D. J., Sangar, D. V., Brown, F.: Stabilizing the immunizing antigen of foot-and-mouth disease virus by fixation with formaldehyde. Arch. ges. Virusforsch.39, 274–283 (1972).Google Scholar
  10. 10.
    Rowlands, D. J., Sangar, D. V., Brown, F.: A comparative chemical and serological study of the full and empty particles of foot-and-mouth disease virus. J. gen. Virol.26, 227–238 (1975).Google Scholar
  11. 11.
    Rweyemamu, M. M., Terry, G., Pay, T. W. F.: Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch. Virol.59, 69–79 (1979).Google Scholar
  12. 12.
    Sangar, D. V., Rowlands, D. J., Smale, C. J., Brown, F.: Reaction of glutaraldehyde with foot-and-mouth disease virus. J. gen. Virol.21, 399–406 (1973).Google Scholar
  13. 13.
    Spier, R. E., Staple, R. F., Prince, M., Rowe, L., Fletton, B., Mowat, G. N.: A simplified process for the production of foot-and-mouth disease vaccine from BHK21 clone 13 suspension cells grown in 10-litre Pyrex reagent bottles. Bull. Off. internat. Epiz.85, 995–1010 (1976).Google Scholar
  14. 14.
    Staple, R. F., Morrow, A. W., Fletton, B. W.: The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4° C. Arch. Virol.47, 331–335 (1975).Google Scholar
  15. 15.
    Wild, T. F., Brown, F.: Nature of the inactivating action of trypsin on foot-and-mouth disease virus. J. gen. Virol.1, 247–250 (1967).Google Scholar
  16. 16.
    Wild, T. F., Brown, F.: A study of the physical properties of the immunising antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure. Arch. ges. Virusforsch.24, 86–103 (1968).Google Scholar
  17. 17.
    Wild, T. F., Burroughs, J. N., Brown, F.: Surface structure of foot-and-mouth disease virus. J. gen. Virol.4, 313–320 (1969).Google Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • T. R. Doel
    • 1
  • P. J. Baccarini
    • 1
  1. 1.Vaccine Research DepartmentAnimal Virus Research InstitutePirbrightEngland

Personalised recommendations